← FDA Drug Approvals (Drugs@FDA)

ANDA211336

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JIANGXI BOYA SEEHOT · Approved 2020-11-06

Drug application

FDA Application #

ANDA211336

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

JIANGXI BOYA SEEHOT

First approval

2020-11-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown